Skip to content

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Joanne Wen Yee Yau, Sophie Rogers, Ryo Kawasaki, Ecosse Luc Lamoureux, Jonathan W. Kowalski, Toke Bek, Shih‐Jen Chen, ASTRID E. FLETCHER, Jakob Grauslund, Steven M. Haffner, Richard F. Hamman, M. Kamran Ikram, Takamasa Kayama, Barbara E.K. Klein, Ronald Klein, Sannapaneni Krishnaiah, Korapat Mayurasakorn, Joseph Paul O’Hare, Trevor John Orchard, Massimo Porta, Mohan Rema, Monique S. Roy, Tarun Sharma, Jonathan E. Shaw, Hugh Ringland Taylor, James M. Tielsch, Rohit Varma, Jie Jin Wang, Ningli Wang, Sheila K. West, Liang Xu, Miho Yasuda, Xinzhi Zhang, Paul L.R. Mitchell, Tien Yin Wong

Diabetes Care · 2012 · 5,182 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Yau, J. W. Y., Rogers, S., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S., Dekker, J. M., FLETCHER, A. E., Grauslund, J., Haffner, S. M., Hamman, R. F., Ikram, M. K., Kayama, T., Klein, B. E., Klein, R., Krishnaiah, S., Mayurasakorn, K., O’Hare, J. P., … Group, for the M.-A. for E. D. (META-E. S. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3), 556–564. https://doi.org/10.2337/dc11-1909

In text: (Yau et al., 2012)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

OBJECTIVE: To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. RESEARCH DESIGN AND METHODS: A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20-79 years. RESULTS: A total of 35 studies (1980-2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5-34.8) for any DR, 6.96% (6.87-7.04) for proliferative DR, 6.81% (6.74-6.89) for diabetic macular edema, and 10.2% (10.1-10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A(1c), and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. CONCLUSIONS: There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics.

  1. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs2016
  2. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis2014
  3. Ridge-Based Vessel Segmentation in Color Images of the Retina2004
  4. Human photoreceptor topography1990

Metadata from OpenAlex (CC0). Citations are generated from the published record.